The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
TECHNOLOGY
Hundreds of millions at risk from Chinese shopping app malware
Hundreds of millions at risk from Chinese shopping app malware
CNN·22h ago
